Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Historical Holders from Q1 2021 to Q3 2025

Symbol
TERN on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
87.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
88.6M
Holdings value
$666M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
139
Number of buys
70
Number of sells
-55
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.6% $23.8M 8.14M Soleus Capital Master Fund, L.P. 31 Dec 2024
Deep Track Capital, LP 8.58% +36.5% $36.7M $9.4M 7.5M +34.4% Deep Track Capital, LP 30 Jun 2025
MORGAN STANLEY 8.1% $20.7M 7.1M Morgan Stanley 31 Mar 2025
BlackRock, Inc. 6.8% $16.8M 5.74M BlackRock, Inc. 31 Dec 2024
Commodore Capital LP 6.5% +24% $42.8M $7.89M 5.7M +22.6% Commodore Capital LP 30 Sep 2025
VANGUARD GROUP INC 5.21% $34.2M 4.56M The Vanguard Group 30 Sep 2025
Schonfeld Strategic Advisors LLC 4.93% -20.5% $12.6M -$2.71M 4.31M -17.8% Schonfeld Strategic Advisors LLC 31 Mar 2025
ORBIMED ADVISORS LLC 4.8% $31.8M 4.24M ORBIMED ADVISORS LLC 03 Nov 2025
CITADEL ADVISORS LLC 4.1% $10.1M 3.47M Kenneth Griffin 31 Dec 2024

Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 88.6M $666M +$50.6M $7.51 139
2025 Q2 83.1M $310M +$2.35M $3.73 126
2025 Q1 83.1M $229M -$20.9M $2.76 134
2024 Q4 86.1M $477M +$3.83M $5.54 156
2024 Q3 79.5M $663M +$119M $8.34 153
2024 Q2 65.6M $447M +$17.2M $6.81 124
2024 Q1 63.2M $415M -$1.82M $6.56 112
2023 Q4 63.6M $413M +$14M $6.49 102
2023 Q3 61.7M $310M +$8.57M $5.03 92
2023 Q2 57.7M $505M +$31.7M $8.75 102
2023 Q1 53.2M $630M +$46.2M $11.84 79
2022 Q4 49.7M $506M +$199M $10.18 65
2022 Q3 30.2M $178M +$107M $5.89 43
2022 Q2 14.7M $36.5M -$6.46M $2.48 37
2022 Q1 16.8M $50M -$1.39M $2.97 43
2021 Q4 16.5M $117M -$4.53M $7.07 37
2021 Q3 16.7M $174M +$980K $10.42 33
2021 Q2 16.6M $204M -$24.8M $12.26 36
2021 Q1 17.9M $394M +$393M $22.00 41